This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Seed Company Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Rei Uchida: Innovator in Ophthalmic Lens Technology
Introduction
Rei Uchida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of ophthalmic technology, particularly in the development of lenses that can effectively deliver medication. Her innovative approach combines advanced materials with practical applications, making her a key figure in her industry.
Latest Patents
Rei Uchida holds a patent for "Ophthalmic lenses capable of sustained drug release and preservative solutions therefor." This invention aims to provide a practical ophthalmic lens that effectively retains and releases drugs while maintaining form stability. The lens utilizes an ionic polymer gel that regulates the drug's release based on its efficacy. This technology represents a significant advancement in drug delivery systems for ophthalmic applications.
Career Highlights
Rei Uchida is currently associated with Seed Company Limited, where she continues to innovate in the field of ophthalmic lenses. Her work has garnered attention for its potential to improve patient outcomes through enhanced drug delivery methods. With her expertise, she is paving the way for future advancements in ophthalmic technology.
Collaborations
Rei has collaborated with notable colleagues, including Takao Sato and Kenji Uno. These partnerships have allowed her to expand her research and contribute to the development of cutting-edge ophthalmic solutions.
Conclusion
Rei Uchida's contributions to ophthalmic lens technology highlight her role as a leading inventor in the field. Her innovative patent for drug delivery lenses showcases her commitment to improving healthcare solutions. Through her work, she continues to inspire advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
